Evidence map›Paper›PMID 28951836›Full record

ReviewIntegrative medicine research2017

Pharmacognostic outlooks on medical herbs of Sasang typology.

Su Hye Lim, Eun Sang Jeon, Jeongyun Lee, Sang Yun Han, Han Chae

Open access · goldAbstract readReview
In one paragraph

Review in Integrative medicine research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. An Evaluation of the DNA-Protective Effects of Extracts fromOxidative medicine and cellular longevity · 2019
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Su Hye LimDepartment of Pharmacognosy, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.
Eun Sang JeonDivision of Longevity and Biofunctional Medicine, School of Korean Medicine, Pusan National University, Busan, Korea.
Jeongyun LeeKorea Institute of Oriental Medicine, Daejeon, Korea.
Sang Yun HanDivision of Longevity and Biofunctional Medicine, School of Korean Medicine, Pusan National University, Busan, Korea.
Han ChaeDivision of Longevity and Biofunctional Medicine, School of Korean Medicine, Pusan National University, Busan, Korea.
Pusan National University · KRIstanbul Medipol University · TRIstanbul University · TRKorea Institute of Oriental Medicine · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to review the pharmacognostic characteristics of Sasang type-specific medical herbs and suggest biological mechanisms that might be related to the personalized treatment of the East. Major compounds and their pharmacological activities of medical herbs for each Sasang types were systematically reviewed. The pharmacognostic characteristics of its main compounds were systematically analyzed with previous studies and three web-based databases. Sasang type-specific medical herbs were selected, and biological effects of their phytochemicals were reviewed from the pathophysiological features of each Sasang types. Phenolics were dominant in Tae-Yang type-specific herbs, iridoids and triterpenes with antipyretic and diuretic effects were in So-Yang type-specific, saponins (triterpene saponins and steroidal saponins) with antitussive effects were in Tae-Eum type-specific, and monoterpene and sesquiterpenes with stomachic effect were in So-Eum type-specific herbs. Pharmacognostic understandings on Sasang type-specific medical herbs with consideration of type-specific pathophysiological features were provided for the first time. This study would contribute to in-depth understandings on the pathophysiology of Sasang typology and integration of East-Asian and Western personalized medicine.

Indexed as

medical herbpersonalized medicinepharmacognosySasang typology

Identifiers

PMID28951836
PMCPMC5605368
OpenAlexW2725713483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.